Abstract Coronavirus disease 2019 (COVID-19) outbreak has become a global public health
emergency and has led to devastating results. Mounting evidence proposes that the disease …

Acute respiratory distress syndrome (ARDS) is a heterogeneous cause of respiratory failure
that has a rapid onset, a high mortality rate, and for which there is no effective …

Acute lung injury/acute respiratory distress syndrome (ALI/ARDS) or pulmonary fibrosis (PF)
has been regarded as a global health issue with high mortality and limited drug therapy …

Background The severity of COVID-19 is associated with an elevated level of a variety of
inflammatory mediators. Increasing evidence suggests that the Th17 response contributes to …

Acute lung injury (ALI) is a life-threatening disease that has received considerable critical
attention in the field of intensive care. This study aimed to explore the role and mechanism of …

The acute exudative phase of acute respiratory distress syndrome (ARDS), a severe form of
respiratory failure, is characterized by alveolar damage, pulmonary oedema, and an …

Abstract Background Dexamethasone (Dexa) has been recently found to exert an analgesic
effect, whose action is closely related to IL-8. However, whether dexamethasone induces …

Dexamethasone (DEXA) is a potent corticosteroid, commonly used for treating inflammatory,
hypersensitive and allergic conditions. It is administered to birds with tumours. Many studies …

Background Acute respiratory distress syndrome (ARDS) and acute lung injury are important
clinical problems in intensive care units. The most common extrapulmonary organ failure in …

Le syndrome de détresse respiratoire aiguë (SDRA) est une forme sévère de défaillance
respiratoire qui se caractérise par la présence de dommages alvéolaires, d'un oedème …